Home/Filings/4/0001127602-16-056139
4//SEC Filing

Edge Therapeutics, Inc. 4

Accession 0001127602-16-056139

$PDSBCIK 0001472091operating

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 9:53 AM ET

Size

4.8 KB

Accession

0001127602-16-056139

Insider Transaction Report

Form 4
Period: 2016-06-21
Conti Kurt G
Director
Transactions
  • Award

    Stock Option (right To Purchase)

    2016-06-21+15,00015,000 total
    Exercise: $9.34From: 2017-06-21Exp: 2026-06-21Common Stock (15,000 underlying)

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001472091

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:53 AM ET
Size
4.8 KB